NORRIS MEDICINES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Norris Medicines along with daily highs, lows, percentage changes and volume trends, and, all financial information.
5.62₹ 0.90
As on Dec 24, 2025, 4:01 PM IST
Norris Medicines Price Performance
Today's LowToday's High
₹15.51₹16.99
₹16.90
52 Weeks' Low52 Weeks' High
₹14.00₹24.65
₹16.90
Open Price
₹16.00
Prev. Close
₹16.00
Volume
1,353
Over the last 5 years, the share price of Norris Medicines has gained 22.61% CAGR. Over the past year, the corresponding return has been -8.15%.
Norris Medicines’s current P/E of -10.99x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Norris Medicines Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Norris Medicines | 1.62 | 9.17 | 5.49 | -10.82 | -8.15 | 8.56 | 22.61 |
| Sun Pharmaceutical Industries | -3.21 | -2.45 | 6.80 | 4.59 | -4.41 | 20.27 | 24.12 |
| Divi's Laboratories | 3.16 | 2.12 | 8.52 | -1.10 | 12.27 | 23.69 | 11.61 |
| Torrent Pharmaceuticals | 1.66 | 3.04 | 5.99 | 20.58 | 12.65 | 34.66 | 22.45 |
| Cipla | -0.09 | -0.55 | -2.74 | -0.48 | 1.34 | 10.91 | 12.41 |
| Dr. Reddy's Laboratories | -0.32 | 3.53 | -2.41 | -5.19 | -6.16 | 14.28 | 4.03 |
| Lupin | -0.34 | 5.37 | 5.77 | 9.08 | -2.87 | 41.56 | 16.62 |
| Zydus Lifesciences | -0.10 | -0.99 | -11.37 | -4.92 | -4.87 | 29.70 | 13.38 |
| Mankind Pharma | 4.19 | -0.96 | -13.08 | -4.75 | -24.46 | 15.58 | 9.07 |
| Aurobindo Pharma | 1.42 | 1.31 | 10.86 | 9.60 | -4.14 | 40.40 | 5.89 |
| Alkem Laboratories | -1.08 | -1.09 | -0.16 | 15.83 | 2.90 | 21.81 | 13.77 |
| Abbott India | 3.45 | -3.72 | -5.10 | -9.18 | 0.54 | 9.56 | 12.70 |
| Laurus Labs | 7.56 | 10.69 | 19.40 | 62.17 | 91.40 | 41.66 | 25.52 |
| Glenmark Pharmaceuticals | 3.41 | 9.40 | -0.18 | 19.75 | 31.11 | 67.86 | 32.33 |
| Biocon | 3.02 | 0.86 | 10.92 | 14.09 | 15.44 | 14.51 | -3.75 |
| GlaxoSmithKline Pharmaceuticals | -3.94 | 0.21 | -9.76 | -23.16 | 9.49 | 23.09 | 10.09 |
| Anthem Biosciences | 0.48 | 5.66 | -18.74 | -8.61 | -8.61 | -2.95 | -1.78 |
| Ipca Laboratories | 1.11 | -0.60 | 4.56 | 5.82 | -10.75 | 18.53 | 5.49 |
| Ajanta Pharma | 4.74 | 8.33 | 7.59 | 6.14 | -2.83 | 32.00 | 19.59 |
| J B Chemicals & Pharmaceuticals | 0.89 | 3.29 | 6.77 | 0.62 | -2.99 | 23.13 | 28.52 |
Over the last one year, Norris Medicines has declined 8.15% compared to peers like Sun Pharmaceutical Industries (-4.41%), Divi's Laboratories (12.27%), Torrent Pharmaceuticals (12.65%). From a 5 year perspective, Norris Medicines has outperformed peers relative to Sun Pharmaceutical Industries (24.12%) and Divi's Laboratories (11.61%).
Norris Medicines Financials
Norris Medicines Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 16.81 | 16.32 |
| 10 | 16.14 | 16.19 |
| 20 | 15.54 | 15.94 |
| 50 | 15.83 | 15.92 |
| 100 | 16.23 | 16.3 |
| 200 | 17.09 | 16.85 |
Norris Medicines Share Holding Pattern
In the latest quarter, Norris Medicines remained same as its previous close in promoter holding, while DII stake unchanged at 0.07%, FII holding unchanged at 0.00%, and public shareholding moved down to 65.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Norris Medicines Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 12, 2025, 11:27 PM IST | Norris Medicines - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Dec 12, 2025, 9:56 PM IST | Norris Medicines - Intimation Regarding Completion Of NAFDAC Audit (Nigeria) Of Norris Medicines Limited. |
| Dec 12, 2025, 1:58 AM IST | Norris Medicines - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order |
| Nov 15, 2025, 12:08 AM IST | Norris Medicines - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday, November 14, 2025 |
| Nov 08, 2025, 7:03 PM IST | Norris Medicines - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requ |
About Norris Medicines
Norris Medicines Ltd. is a Public Limited Listed company incorporated on 07/09/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1990PLC086581 and registration number is 086581. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 5.82 Cr. and Equity Capital is Rs. 9.93 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 801/P, GIDC Industrial Estate, Ankleshwar Gujarat 393002
- Contact
Management
- Mr. Vimal ShahExecutive Director
- Mr. Praveen BafnaNon Executive Director
- Mr. A VadivelIndependent Director
- Ms. Sathya VenkatachalamIndependent Director
FAQs on Norris Medicines Share Price
What is the share price of Norris Medicines?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Norris Medicines is ₹16.90 as on Dec 24, 2025.
What kind of stock is Norris Medicines?
The Norris Medicines is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Norris Medicines?
The market cap of Norris Medicines is ₹16.90 Cr as on Dec 24, 2025.
What are today's High and Low prices of Norris Medicines?
Today’s highest and lowest price of Norris Medicines are ₹16.99 and ₹15.51.
What are the 52 Week High and 52 Week Low of Norris Medicines?
The 52-week high/low is the highest and lowest price at which Norris Medicines stock has traded in the past 52-week or nearly a year. The 52-week high of Norris Medicines is ₹24.65 and 52-week low of Norris Medicines is ₹14.00 as on Dec 24, 2025.
How has the Norris Medicines performed historically in terms of returns?
The Norris Medicines has shown returns of 5.62% over the past day, 9.17% for the past month, 5.49% over 3 months, -8.15% over 1 year, 8.56% across 3 years, and 22.61% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Norris Medicines?
P/E ratio of and PB ratio of Norris Medicines are -10.99 and -1.07 on Dec 24, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse